SciSparc Presents New Leadership Lineup

TEL AVIV, Israel, Jan. 27, 2022 -- (Healthcare Sales & Marketing Network) -- SciSparc Ltd. (NASDAQ: SPRC) a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the &qu... Biopharmaceuticals, Neurology, Personnel SciSparc, Tourette syndrome, obstructive sleep apnea, Alzheimer's disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news